JP2010505795A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505795A5
JP2010505795A5 JP2009530876A JP2009530876A JP2010505795A5 JP 2010505795 A5 JP2010505795 A5 JP 2010505795A5 JP 2009530876 A JP2009530876 A JP 2009530876A JP 2009530876 A JP2009530876 A JP 2009530876A JP 2010505795 A5 JP2010505795 A5 JP 2010505795A5
Authority
JP
Japan
Prior art keywords
composition
use according
chlamydia trachomatis
pmpdpd
momp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009530876A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010505795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/060500 external-priority patent/WO2008040757A1/en
Publication of JP2010505795A publication Critical patent/JP2010505795A/ja
Publication of JP2010505795A5 publication Critical patent/JP2010505795A5/ja
Pending legal-status Critical Current

Links

JP2009530876A 2006-10-04 2007-10-03 クラミジア感染症に対するワクチン Pending JP2010505795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82809206P 2006-10-04 2006-10-04
PCT/EP2007/060500 WO2008040757A1 (en) 2006-10-04 2007-10-03 Vaccines against chlamydial infection

Publications (2)

Publication Number Publication Date
JP2010505795A JP2010505795A (ja) 2010-02-25
JP2010505795A5 true JP2010505795A5 (https=) 2010-11-25

Family

ID=39092594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009530876A Pending JP2010505795A (ja) 2006-10-04 2007-10-03 クラミジア感染症に対するワクチン

Country Status (11)

Country Link
US (1) US20100172927A1 (https=)
EP (1) EP2068916A1 (https=)
JP (1) JP2010505795A (https=)
KR (1) KR20090077065A (https=)
CN (1) CN101522215A (https=)
AU (1) AU2007304199A1 (https=)
BR (1) BRPI0719169A2 (https=)
CA (1) CA2664236A1 (https=)
EA (1) EA200900338A1 (https=)
MX (1) MX2009003127A (https=)
WO (1) WO2008040757A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
EP3220962A4 (en) * 2014-11-21 2018-07-25 Merck Sharp & Dohme Corp. Recombinant expression of chlamydia momp antigen
CN104800841B (zh) * 2015-03-02 2019-04-02 中国农业科学院兰州兽医研究所 牦牛流产衣原体灭活疫苗及其制备方法
CN111735967B (zh) * 2020-08-03 2020-12-22 天津中逸安健生物科技有限公司 一种重组新型冠状病毒疫苗吸附完全性检测方法
AR132053A1 (es) 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia
WO2025076210A1 (en) * 2023-10-03 2025-04-10 Vaxcyte, Inc. Chlamydia vaccine compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100132086A (ko) * 1998-12-08 2010-12-16 코릭사 코포레이션 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트
US20020146776A1 (en) * 2000-04-21 2002-10-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20030199438A1 (en) * 2001-04-09 2003-10-23 Shaw Allan Christian Method for identification of proteins from intracellular bacteria
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
CN100515494C (zh) * 2001-12-12 2009-07-22 启龙有限公司 抗沙眼衣原体的免疫
WO2005027961A2 (en) * 2003-09-23 2005-03-31 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Chlamydia pmpd autotransporter and its role as adhesin
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease

Similar Documents

Publication Publication Date Title
JP2010505795A5 (https=)
JP2008534594A5 (https=)
UA97943C2 (ru) Вакцина против инфекции chlamydia
EA200900338A1 (ru) Вакцины против хламидийной инфекции
WO2004014418A3 (en) Neisserial vaccine compositions comprising a combination of antigens
JP2016040284A5 (https=)
JP2007538044A5 (https=)
EP2181714A3 (en) Immunogenic composition for use in vaccination against staphylococcei
WO2008054540A3 (en) Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
WO2008124647A3 (en) Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
JP2013502918A5 (https=)
WO2006031825A3 (en) Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
CL2013002106A1 (es) Composicion inmunogenica de streptococcus pneumoniae que comprende 2 o mas conjugados de sacarido capsular de diferentes serotipos; vacuna que la comprende; procedimiento de fabricacion; y su uso para tratar o prevenir enfermedades causadas por la infeccion por streptococcus pneumoniae (div.sol.n°3625-2006).
WO2008020335A8 (en) Immunogenic compositions for streptococcus agalactiae
JP2009520758A5 (https=)
JP2016502551A5 (https=)
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
JP2016522259A5 (https=)
JP2015529677A5 (https=)
WO2005028618A3 (en) Immunogenic compositions for streptococcus agalactiae
BR0208367B1 (pt) Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina
WO2001078774A3 (en) Recombinant intracellular pathogen vaccines and methods for use
WO2008153772A3 (en) Chlamydia vaccine comprising htra polypeptides
EP2270171A3 (en) Haemophilus influenzae antigens and corresponding DNA fragments
WO2009071613A3 (en) Vaccine